Amova Asset Management Americas, Inc.
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1480751
NEW YORK, NY
Position in RXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,227,891
+$3,590,883 QoQ
Shares Held
5,511,687
+1.7% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#13
of 340 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amova Asset Management Americas, Inc. holds $354,236,903 across 20 Biotechnology names. RXRX ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
1,720,097 | $93,814,090 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
2,897,529 | $49,026,190 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
983,462 | $23,858,788 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
5,511,687 | $20,227,891 | |
| 6 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
1,960,458 | $13,174,277 | |
| 7 | ABSI |
Absci Corp
|
1,013,965 | $11,751,854 | |
| 8 | PRME |
Prime Medicine, Inc.
|
2,407,018 | $8,881,896 |
All Filings in RXRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,227,891 | 5,511,687 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $16,637,008 | 5,419,221 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $25,443,992 | 6,221,025 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $36,433,387 | 7,465,858 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $41,328,789 | 8,167,745 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $44,474,796 | 8,407,334 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $60,222,480 | 8,908,651 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $63,888,587 | 9,694,778 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $74,508,682 | 9,934,491 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $103,317,145 | 10,362,803 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $90,749,270 | 9,203,780 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $26,951,898 | 3,523,124 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,255,378 | 837,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,348,186 | 501,977 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,504,364 | 454,522 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,221,473 | 490,740 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,255,194 | 399,901 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,973,318 | 415,268 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $6,320,867 | 368,994 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $9,415,553 | 409,194 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $8,608,379 | 235,846 | Shares | Sole | 2021-08-09 | |
| No filing history on record for this holder in this stock. | ||||||